Company / Income Tax
Corcept Therapeutics Incorporated Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$33.2M
FY2025
5-year range
-$33.2M / $25.6M
FY2021-FY2025
Trend
-263.6%
vs FY2024
Sector context
#196 of 204
Health Care
What the data says
Income Tax changed -264% YoY in FY2025, a notable deviation from the 7-year average annual change of -2%.
Based on SEC 10-K filings.
-$33M in FY2025.
Improved from $18M to -$33M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 204This company -$33.2M Sector average $118.7M
▼
-128.0% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 263.6% year-over-year.
- Ranks #196 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$33.2M | -263.6% |
| FY2024 | $20.3M | +10.1% |
| FY2023 | $18.4M | -28.0% |
| FY2022 | $25.6M | +13.8% |
| FY2021 | $22.5M | +34.4% |
| FY2020 | $16.7M | +121.9% |
| FY2019 | -$76.3M | - |
| FY2018 | $0 | +100.0% |
| FY2017 | -$76.3M | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026